Floatz logo

Vinorelbine

Zollinger Ellison Syndrome

Vanderbilt-Ingram Cancer CenterPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Zollinger Ellison Syndrome cohort.

Asset / SponsorPhaseRating
Omeprazole
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B
Inno-206
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B
Streptozocin
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B
FLUOROURACILUM
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B
PANTOPRAZOLE
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 2B

View all 10 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →